RPAM
AIMT
Rhenman & Partners Asset Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-285,000
| Closed | -$4.76M | – | 94 |
|
|
2020
Q2 | $4.76M | Buy |
285,000
+120,000
| +73% | +$2.01M | 0.51% | 64 |
|
|
2020
Q1 | $2.38M | Buy |
165,000
+15,000
| +10% | +$216K | 0.33% | 73 |
|
|
2019
Q4 | $5.02M | Buy |
150,000
+799
| +0.5% | +$26.7K | 0.55% | 63 |
|
|
2019
Q3 | $3.12M | Hold |
149,201
| – | – | 0.39% | 67 |
|
|
2019
Q2 | $3.11M | Hold |
149,201
| – | – | 0.34% | 65 |
|
|
2019
Q1 | $3.34M | Buy |
+149,201
| New | +$3.34M | 0.39% | 66 |
|